Nycomed acquires Bruker contrast injector

AuntMinnie.com staff writers
Jan 23, 2001

Today Nycomed Amersham Imaging announced its acquisition of the Bruker Tomojet power injector system from Swiss firm Bruker. Tomojet is a pump injector for the administration of contrast media for diagnostic investigations, and is available in versions suitable for both MR and CT applications, according to Nycomed Amersham of Buckinghamshire, U.K.

Typical applications for Tomojet include: contrast angiography, tumor diagnostics, organ perfusion, and incremental body imaging, according to Nycomed Amersham. Tomojet is currently being marketed in Europe and other international markets, and will continue to be manufactured by Bruker in Zurich, Switzerland.

By AuntMinnie.com staff writers
January 24, 2001

Related Reading

E-Z-EM inks European deal with Nycomed-Amersham, December 18, 2000

Copyright © 2001 AuntMinnie.com

Latest in CT
Liver Cancer
CT-based AI algorithm comparable to rads for identifying renal masses
May 15, 2024
You think ahead. We innovate ahead.
Sponsored
You think ahead. We innovate ahead.
May 1, 2024
Artificial Intelligence Ai Social
AI stroke software differences don't affect thrombectomy eligibility
May 3, 2024
Lung Cancer
Volumetric CT helps predict lung-lobectomy complications
May 1, 2024
Related Stories
2001 01 19 17 40 05 706
CT
Prior chemotherapy doesn't affect outcomes in liver tumor ablation
Appendix Rn 2001 01 15 Small
CT
Focused CT preferred over US for tracking suspected appendicitis in pregnant women
Positracesmall
CT
SMV wins FDA clearance for Positrace hybrid PET/CT camera
You think ahead. We innovate ahead.
Sponsor Content
You think ahead. We innovate ahead.
More in CT
CT-based AI algorithm comparable to rads for identifying renal masses
By Kate Madden Yee
A multiphase CT-based AI algorithm shows comparable performance to radiologists for identifying benign small renal masses.
May 15, 2024
Liver Cancer
CT perfusion, portable MRI viable alternatives for evaluating dizziness
By Kate Madden Yee
CT perfusion and portable MRI are clinically viable alternatives to typical CT or CT angiography imaging for evaluating dizziness.
May 14, 2024
Brain Abstract
AI stroke software differences don't affect thrombectomy eligibility
By Liz Carey
The research findings suggest, however, that scanner model and local CT perfusion protocols can influence performance and cause discrepancies.
May 3, 2024
Artificial Intelligence Ai Social
Volumetric CT helps predict lung-lobectomy complications
By Kate Madden Yee
Volumetric CT imaging analysis shows promise for helping determine lung function in lung cancer patients undergoing pulmonary lobectomy.
May 1, 2024
Lung Cancer
Interstitial lung abnormalities linked to respiratory disease risk
By Kate Madden Yee
CT imaging shows that severe acute respiratory disease events can be caused by quantitative interstitial abnormalities.
April 30, 2024
2024 04 30 Radiology Choi Figure2 Thumbnail
Understanding CT flow artifacts is key to better disease diagnosis
By Kate Madden Yee
Understanding the mechanics of flow artifacts on CT or CT angiography and how these artifacts are created is key to better disease diagnosis.
April 26, 2024
2024 04 25 Radio Graphics Robb Figure7 Thumbnail
CT reveals influence of diabetes on COVID-19 severity
By Kate Madden Yee
CT imaging reveals the influence of blood glucose levels on the severity of COVID-19, researchers have reported.
April 25, 2024
3 D Lungs Covid Virus Cells
Clinical practice LCS program finds more disease than NLST
By Kate Madden Yee
A clinical practice lung cancer screening (LCS) program at Duke University Medical Center found more disease than did the National Lung Screening Trial (NLST).
April 24, 2024
Lung Illustration Blue
Novel risk prediction model improves LCS uptake
By Kate Madden Yee
A novel risk prediction model used in the Ontario Lung Cancer Screening Pilot increased the uptake of lung cancer screening among eligible Canadians, researchers have found.
April 23, 2024
Lung Cancer
Radiologist consultation improves patients' LCS attitudes
By Kate Madden Yee
Consulting with a radiologist boosts patients' attitudes toward lung cancer screening (LCS) and their interest in quitting smoking, researchers have reported.
April 18, 2024
Doctor Female Young Desk 400
Tailored lung cancer screening model helps determine nodule follow-up
By Kate Madden Yee
A personalized lung cancer screening model used with patients with pulmonary nodules identified on low-dose CT helps clinicians determine how to follow up better than rule-based protocols, researchers have found.
April 17, 2024
Lung Cancer
CT-based deep learning identifies patients at further lung cancer risk
By Kate Madden Yee
A CT-based deep learning model can identify individuals with clinical stage IA non-small cell lung cancer (NSCLC) at high risk of further disease, researchers have found.
April 16, 2024
Ai
Page 1 of 654
Next Page